20 jun: Germany's Schaeuble: Common European Fiscal Policy To Em..
20 jun: EUROBONDS: Primary Springs To Life, Indexes Tighten
20-06-2012 14:38:00

WSJ BLOG/Health: A.M. Vitals: Untreatable TB Strain in India

Relateret indhold

(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.)

By Shirley S. Wang

Here's what's making health news this morning:

India in Race to Contain Untreatable Tuberculosis (WSJ): A new treatment-resistant strain of TB has emerged in India, and some health experts are skeptical about the country's ability to contain it.

Walgreen's Europe Bet (WSJ): Walgreens is investing nearly $7 billion to buy a 45% stake in European pharmacy giant Boots Alliance to gain purchasing power with generic drugs manufacturers and together will operate 11,000 stores.

Turning to Frogs for Illegal Aid in Horse Races (NY Times): A potent painkiller from frogs has been detected in horse racing and may soon lead to trainers being charged for violating the industry's drug regulations.

Pizza Chains Band Together Over Proposed Menu-Labeling Plan (WaPo): A coalition of pizza chains is battling against lawmakers who are proposing menu labeling changes that would require chain restaurants to post calorie counts, saying that pizza's customization would make it difficult for them to post such information.

Samsonite Pulls Tokyo Chic Luggage Amid Carcinogen Claims (Bloomberg): The world's biggest maker of branded luggage is pulling its Tokyo Chic line off the market after reports that its handles contain a carcinogen, but the company said it has "absolute conviction" that the line is safe for consumers.

-For continuously updated news from The Wall Street Journal, see WSJ.com at http://wsj.com.

(END) Dow Jones Newswires

June 20, 2012 08:38 ET (12:38 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Aarhus Elite Q3: Venter underskud på 14-16 mio. kr.

24-04-2014 15:58:12
Århus Elite har sat tal på, hvor stort underskud, der er i vente i 2013/14. 14-16 mio. kr. bliver tabet. Der var hidtil ventet et resultat, der var dårligere en..

Novo/Sydbank: Kontrakttab viser sig ikke i Lillys tal

24-04-2014 13:20:33
Eli Lillys regnskab for første kvartal viser ikke klare tegn på, at selskabet nyder godt af at have vundet en kontrakt for næsen af Novo Nordisk sidste år.Salge..

Vind/Sydbank: Alstom-opkøb vil give GE et ekstra ben

24-04-2014 11:29:02
Såfremt rygterne om, at General Electric vil købe franske Alstom holder vand, vil det på sigt kunne skabe en stærkere spiller på vindmarkedet, når to selskaber ..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Aktier/tendens: Forstærkede forventninger i fokus hos Novozymes
2
Apple blæste analytikernes estimater af banen
3
Økonom: Godt nyt til Danmark fra Tyskland
4
Torsdagens aktier: Russisk sabelraslen sendte markedet ned
5
Danmark: Nationalbanken dropper negativ rente - NY

Relaterede aktiekurser

Walgreen Co 67,42 0,0% Stigning i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Relaterede selskaber
Få adgang til information og anbefalinger af relaterede selskaber med PLUS pakken.

Du får adgang til 7 værdifulde investorværktøjer til investering.

Klik her og læs mere om PLUS pakken.
Euroinvestor i andre lande: Euroinvestor.com | Euroinvestor.se | Euroinvestor.no | Euroinvestor.fr | Forexinvestor.com| Wisselkoersen.nl | Valuta.se | Valutaveksel.no | Divisas.es | Valute.it
Copyright Euroinvestor A/S 2014  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
25. april 2014 02:36:28
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20140324.1 - EUROWEB6 - 2014-04-25 02:36:28 - 2014-04-25 02:36:28 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x